Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efatutazone + FOLFIRI in metastatic colorectal cancer
NCT00967616Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2009
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of efatutazone in metastatic colorectal cancer (mCRC), sponsored by Daiichi Sankyo Co., Ltd.. Started Sep 2009; status: completed.
02
Drugs
efatutazone
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00967616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967616.